AmirMehrvarz SarshekehMD

PubMed

• 26 citations
  ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer.
  Amir Mehrvarz Sarshekeh, Jumanah Alshenaifi, Jason Roszik, Ganiraju C. Manyam, Shailesh Advani, Riham Katkhuda, Anuj Verma, Michael Lam, Jason Willis, John Paul Shen, ...> ;Clinical Cancer Research. 2021 Jan 7
• 2 citations
  Patient-reported Symptom Outcomes and Microsatellite Instability in Patients With Metastatic Colorectal Cancer
  Shailesh Advani, Quilling Shi, Michael J. Overman, Jonathan M. Loree, Michael Nguyen Minh Chau Lam, Van K. Morris, Imad Shureiqi, Bryan K. Kee, Arvind Dasari, Eduardo ...> ;Clinical Colorectal Cancer. 2020 Mar 1
• 13 citations
  Racial Differences in the Incidence and Survival of Patients With Neuroendocrine Tumors.
  Chan Shen, Dian Gu, Shouhao Zhou, Ying Xu, Amir Mehrvarz Sarshekeh, Daniel M. Halperin, Ya Chen T. Shih, James C. Yao, Arvind Dasari> ;Pancreas. 2019 Nov 1
• 17 citations
  Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.
  Shailesh Advani, Pragati Shailesh Advani, Derek Brown, Stacia M. DeSantis, Krittiya Korphaisarn, Helena M. VonVille, Jan Bressler, David S. Lopez, Jennifer S. Davis, C...> ;BMC Cancer. 2019 Oct 17
• 1 citations
  Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules.
  Kamalesh Kumar Sankhala, Chris H. Takimoto, Alain C. Mita, Henry Xiong, Jordi Rodon, Amir Mehrvarz Sarshekeh, K. Burns, Kenzo Iizuka, Scott Kopetz> ;Investigational New Drugs. 2019 Feb 1
• 39 citations
  Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis.
  Shailesh Advani, Pragati Advani, Stacia M. DeSantis, Derek Brown, Helena M. VonVille, Michael Lam, Jonathan M. Loree, Amir Mehrvarz Sarshekeh, Jan Bressler, David S. L...> ;Translational Oncology. 2018 Oct 1
• 1 citations
  Phase II study of DFP-10917, a deoxycytidine analog, given by 14-day continuous intravenous infusion for chemotherapy-refractory advanced colorectal cancer
  Amir Mehrvarz Sarshekeh, Henry Q. Xiong, Kenzo Iizuka, Howard S. Hochster, Scott Kopetz> ;Investigational New Drugs. 2018 Jun 13
• 27 citations
  Nivolumab in the treatment of microsatellite instability high metastatic colorectal cancer.
  Amir Mehrvarz Sarshekeh, Michael J. Overman, Scott Kopetz> ;Future Oncology. 2018 Feb 23
• 32 citations
  Regional lymph node involvement and outcomes in appendiceal neuroendocrine tumors: a SEER database analysis
  Amir Mehrvarz Sarshekeh, Shailesh Advani, Daniel M. Halperin, Claudius Conrad, Chan Shen, James C. Yao, Arvind Dasari> ;Oncotarget. 2017 Aug 19
• 57 citations
  Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
  Amir Mehrvarz Sarshekeh, Shailesh Advani, Michael J. Overman, Ganiraju C. Manyam, Bryan K. Kee, David R. Fogelman, Arvind Dasari, Kanwal Pratap Singh Raghav, Eduardo V...> ;Plos One. 2017 Mar 7
• 36 citations
  High-Grade Neuroendocrine Colorectal Carcinomas: A Retrospective Study of 100 Patients
  Bruno Conte, Ben George, Michael J. Overman, Jeannelyn S. Estrella, Zhi-Qin Jiang, Amir Mehrvarz Sarshekeh, Renata Ferrarotto, Paulo M. Hoff, Asif Rashid, James C. Yao...> ;Clinical Colorectal Cancer. 2016 Jun 1
• 4 citations
  Update on management of midgut neuroendocrine tumors.
  Amir Mehrvarz Sarshekeh, Daniel M. Halperin, Arvind Dasari> ;International Journal of Endocrine Oncology. 2016 Apr 8
• Join now to see all

Lectures

• ARID1A mutation to define an immunologically active subgroup in patients with microsatellite-stable colorectal cancer. 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
• Association of TGF-β expression with intratumoral infiltration of cytotoxic T lymphocytes in patients with microsatellite-stable colorectal cancer. 
  2019 ASCO Annual Meeting - 6/1/2019
• The characteristics of ARID1A mutations in colorectal cancer. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018